BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30250533)

  • 1. Identification of key pathways and genes in lung carcinogenesis.
    Jin X; Liu X; Zhang Z; Guan Y; Xv R; Li J
    Oncol Lett; 2018 Oct; 16(4):4185-4192. PubMed ID: 30250533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of core serous epithelial ovarian cancer genes as potential prognostic markers and indicators of the underlying molecular mechanisms using an integrated bioinformatics analysis.
    Zhang YB; Jiang Y; Wang J; Ma J; Han S
    Oncol Lett; 2019 Nov; 18(5):5508-5522. PubMed ID: 31612059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hub genes and key pathways of non-small lung cancer identified using bioinformatics.
    Tang Q; Zhang H; Kong M; Mao X; Cao X
    Oncol Lett; 2018 Aug; 16(2):2344-2354. PubMed ID: 30008938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes and pathways in meningioma by bioinformatics analysis.
    Dai J; Ma Y; Chu S; Le N; Cao J; Wang Y
    Oncol Lett; 2018 Jun; 15(6):8245-8252. PubMed ID: 29805558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key candidate genes and biological pathways in the synovial tissue of patients with rheumatoid arthritis.
    Yu F; Hu G; Li L; Yu B; Liu R
    Exp Ther Med; 2022 Jun; 23(6):368. PubMed ID: 35495609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
    Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
    Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis.
    Wu K; Yi Y; Liu F; Wu W; Chen Y; Zhang W
    Oncol Lett; 2018 Jul; 16(1):1003-1009. PubMed ID: 29963176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential diagnostic and prognostic biomarkers for prostate cancer.
    Zhang Q; Yin X; Pan Z; Cao Y; Han S; Gao G; Gao Z; Pan Z; Feng W
    Oncol Lett; 2019 Oct; 18(4):4237-4245. PubMed ID: 31579071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of differentially expressed genes and biological pathways in bladder cancer.
    Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
    Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
    Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
    Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraspanin family identified as the central genes detected in gastric cancer using bioinformatics analysis.
    Qi W; Sun L; Liu N; Zhao S; Lv J; Qiu W
    Mol Med Rep; 2018 Oct; 18(4):3599-3610. PubMed ID: 30106120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
    Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive gene and pathway analysis of cervical cancer progression.
    Yi Y; Fang Y; Wu K; Liu Y; Zhang W
    Oncol Lett; 2020 Apr; 19(4):3316-3332. PubMed ID: 32256826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key candidate genes involved in melanoma metastasis.
    Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
    Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.